306 related articles for article (PubMed ID: 32545380)
1. Apelin Controls Angiogenesis-Dependent Glioblastoma Growth.
Frisch A; Kälin S; Monk R; Radke J; Heppner FL; Kälin RE
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545380
[TBL] [Abstract][Full Text] [Related]
2. Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma.
Mastrella G; Hou M; Li M; Stoecklein VM; Zdouc N; Volmar MNM; Miletic H; Reinhard S; Herold-Mende CC; Kleber S; Eisenhut K; Gargiulo G; Synowitz M; Vescovi AL; Harter PN; Penninger JM; Wagner E; Mittelbronn M; Bjerkvig R; Hambardzumyan D; Schüller U; Tonn JC; Radke J; Glass R; Kälin RE
Cancer Res; 2019 May; 79(9):2298-2313. PubMed ID: 30718358
[TBL] [Abstract][Full Text] [Related]
3. APLN/APLNR Signaling Controls Key Pathological Parameters of Glioblastoma.
Kälin RE; Glass R
Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359800
[TBL] [Abstract][Full Text] [Related]
4. PSMB8 inhibition decreases tumor angiogenesis in glioblastoma through vascular endothelial growth factor A reduction.
Chang HH; Cheng YC; Tsai WC; Chen Y
Cancer Sci; 2020 Nov; 111(11):4142-4153. PubMed ID: 32816328
[TBL] [Abstract][Full Text] [Related]
5. The glycoprotein GP130 governs the surface presentation of the G protein-coupled receptor APLNR.
Trillet K; Jacobs KA; André-Grégoire G; Thys A; Maghe C; Cruard J; Minvielle S; Diest SG; Montagnac G; Bidère N; Gavard J
J Cell Biol; 2021 Sep; 220(9):. PubMed ID: 34287648
[TBL] [Abstract][Full Text] [Related]
6. Vessel co-option in glioblastoma: emerging insights and opportunities.
Seano G; Jain RK
Angiogenesis; 2020 Feb; 23(1):9-16. PubMed ID: 31679081
[TBL] [Abstract][Full Text] [Related]
7. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
Ahir BK; Engelhard HH; Lakka SS
Mol Neurobiol; 2020 May; 57(5):2461-2478. PubMed ID: 32152825
[TBL] [Abstract][Full Text] [Related]
8. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
[TBL] [Abstract][Full Text] [Related]
9. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.
Uribesalgo I; Hoffmann D; Zhang Y; Kavirayani A; Lazovic J; Berta J; Novatchkova M; Pai TP; Wimmer RA; László V; Schramek D; Karim R; Tortola L; Deswal S; Haas L; Zuber J; Szűcs M; Kuba K; Dome B; Cao Y; Haubner BJ; Penninger JM
EMBO Mol Med; 2019 Aug; 11(8):e9266. PubMed ID: 31267692
[TBL] [Abstract][Full Text] [Related]
10. The angiogenic switch leads to a metabolic shift in human glioblastoma.
Talasila KM; Røsland GV; Hagland HR; Eskilsson E; Flønes IH; Fritah S; Azuaje F; Atai N; Harter PN; Mittelbronn M; Andersen M; Joseph JV; Hossain JA; Vallar L; Noorden CJ; Niclou SP; Thorsen F; Tronstad KJ; Tzoulis C; Bjerkvig R; Miletic H
Neuro Oncol; 2017 Mar; 19(3):383-393. PubMed ID: 27591677
[TBL] [Abstract][Full Text] [Related]
11. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma.
Mao XG; Wang C; Liu DY; Zhang X; Wang L; Yan M; Zhang W; Zhu J; Li ZC; Mi C; Tian JY; Hou GD; Miao SY; Song ZX; Li JC; Xue XY
Oncotarget; 2016 Jul; 7(30):47808-47820. PubMed ID: 27329597
[TBL] [Abstract][Full Text] [Related]
13. Apelin (APLN) and Apelin Receptor (APLNR) in Human Ovary: Expression, Signaling, and Regulation of Steroidogenesis in Primary Human Luteinized Granulosa Cells.
Roche J; Ramé C; Reverchon M; Mellouk N; Cornuau M; Guerif F; Froment P; Dupont J
Biol Reprod; 2016 Nov; 95(5):104. PubMed ID: 27683264
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma.
de Boüard S; Herlin P; Christensen JG; Lemoisson E; Gauduchon P; Raymond E; Guillamo JS
Neuro Oncol; 2007 Oct; 9(4):412-23. PubMed ID: 17622648
[TBL] [Abstract][Full Text] [Related]
15. The Hippo-TAZ axis mediates vascular endothelial growth factor C in glioblastoma-derived exosomes to promote angiogenesis.
Wang Z; Yuan Y; Ji X; Xiao X; Li Z; Yi X; Zhu Y; Guo T; Wang Y; Chen L; Liu Y
Cancer Lett; 2021 Aug; 513():1-13. PubMed ID: 34010715
[TBL] [Abstract][Full Text] [Related]
16. High APLN Expression Predicts Poor Prognosis for Glioma Patients.
Lv S; An Y; Dong H; Xie L; Zheng H; Cheng X; Zhang L; Teng T; Wang Q; Yan Z; Guo X
Oxid Med Cell Longev; 2022; 2022():8393336. PubMed ID: 36193059
[TBL] [Abstract][Full Text] [Related]
17. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
[TBL] [Abstract][Full Text] [Related]
18. Loss of cytoskeleton protein ADD3 promotes tumor growth and angiogenesis in glioblastoma multiforme.
Kiang KM; Zhang P; Li N; Zhu Z; Jin L; Leung GK
Cancer Lett; 2020 Apr; 474():118-126. PubMed ID: 31958485
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.
Brunckhorst MK; Wang H; Lu R; Yu Q
Cancer Res; 2010 Sep; 70(18):7283-93. PubMed ID: 20823154
[TBL] [Abstract][Full Text] [Related]
20. CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma.
Angara K; Borin TF; Rashid MH; Lebedyeva I; Ara R; Lin PC; Iskander A; Bollag RJ; Achyut BR; Arbab AS
Neoplasia; 2018 Oct; 20(10):1070-1082. PubMed ID: 30236892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
